US7129390B2
(en)
*
|
1997-10-16 |
2006-10-31 |
Avigenics, Inc |
Poultry Derived Glycosylated Interferon Alpha 2b
|
US20050181482A1
(en)
*
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
EP1088084B1
(de)
*
|
1998-06-15 |
2006-09-13 |
GTC Biotherapeutics, Inc. |
Erythropoietin-analog-menschliches serum-albumin fusionsprotein
|
US20030005468A1
(en)
*
|
1998-06-19 |
2003-01-02 |
Meade Harry M. |
Methods and vectors for improving nucleic acid expression
|
GB9817084D0
(en)
*
|
1998-08-06 |
1998-10-07 |
Wood Christopher B |
A method for promoting extra-heptic production of proteins for the correction of hypoalbuminaemia,anaemia,thrombocytopenia and/or coagulation disorders
|
US7304150B1
(en)
*
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
HUP0202702A2
(hu)
*
|
1999-09-17 |
2002-12-28 |
Genzyme Transgenics Corporation |
Alegységoptimalizált fúziós fehérjék és alkalmazásai
|
CA2391080A1
(en)
*
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Erythropoietin forms with improved properties
|
JP2003530838A
(ja)
*
|
2000-04-12 |
2003-10-21 |
ヒューマン ゲノム サイエンシズ インコーポレイテッド |
アルブミン融合タンパク質
|
US20040226053A1
(en)
*
|
2000-10-13 |
2004-11-11 |
Meade Harry M. |
Methods of producing a target molecule in a transgenic animal and purification of the target molecule
|
JP2004528014A
(ja)
*
|
2000-12-07 |
2004-09-16 |
イーライ・リリー・アンド・カンパニー |
Glp−1融合タンパク質
|
RU2317086C2
(ru)
|
2001-02-02 |
2008-02-20 |
Орто-Макнейл Фармасьютикал, Инк. |
Лечение неврологической дисфункции с применением сульфаматов фруктопиранозы и эритропоэтина
|
US6992174B2
(en)
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
WO2003030821A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
NZ532988A
(en)
|
2001-11-28 |
2008-04-30 |
Ortho Mcneil Pharm Inc |
Erythropoietin dosing regimen for treating anemia
|
CA2471363C
(en)
*
|
2001-12-21 |
2014-02-11 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
CA2484556A1
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7129267B2
(en)
|
2002-03-11 |
2006-10-31 |
Janssen Pharmaceutica N.V. |
Methods for SHP1 mediated neuroprotection
|
DE60332358D1
(de)
*
|
2002-09-09 |
2010-06-10 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
US7803362B2
(en)
*
|
2003-01-24 |
2010-09-28 |
Synageva Biopharma Corp. |
Glycosylated interferon alpha
|
US20040198663A1
(en)
*
|
2003-04-04 |
2004-10-07 |
Baker John E. |
Method of treating cardiac ischemia by using erythropoietin
|
WO2004101620A2
(en)
*
|
2003-05-01 |
2004-11-25 |
Compound Therapeutics, Inc. |
Serum albumin scaffold-based proteins and uses thereof
|
NZ548612A
(en)
|
2004-02-09 |
2009-11-27 |
Human Genome Sciences Inc |
Albumin fusion proteins comprising tandem GLP-1
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
WO2009100255A2
(en)
|
2008-02-08 |
2009-08-13 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
US20060058236A1
(en)
*
|
2004-09-03 |
2006-03-16 |
Hutchins Maria U |
Endogenously-formed conjugate of albumin
|
JP2009520469A
(ja)
*
|
2005-12-22 |
2009-05-28 |
コンジュクヘム ビオテクフノロギエス インコーポレイテッド |
アルブミンと治療薬との前もって形成された抱合体の産生のための方法
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
EP1816201A1
(de)
|
2006-02-06 |
2007-08-08 |
CSL Behring GmbH |
Modifizierter Koagulationsfaktor VIIa mit verbesserter 'half-life'-Stabiltät
|
US7812127B2
(en)
|
2006-03-17 |
2010-10-12 |
Synageva Biopharma Corp. |
Glycosylated human G-CSF
|
KR101492422B1
(ko)
*
|
2006-04-11 |
2015-02-12 |
체에스엘 베링 게엠베하 |
치료용 폴리펩타이드의 생체내 회수율을 증가시키는 방법
|
CN101062407A
(zh)
|
2006-04-29 |
2007-10-31 |
中国科学院上海生命科学研究院 |
促红细胞生成素在预防或治疗视网膜损伤中的用途
|
WO2007146038A2
(en)
|
2006-06-07 |
2007-12-21 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7939632B2
(en)
*
|
2006-06-14 |
2011-05-10 |
Csl Behring Gmbh |
Proteolytically cleavable fusion proteins with high molar specific activity
|
EP2069396B1
(de)
|
2006-09-08 |
2015-10-21 |
Ambrx, Inc. |
Modifiziertes polypeptid oder fc-gerüste aus humanem plasma und ihre verwendung
|
US20090105462A1
(en)
*
|
2006-11-09 |
2009-04-23 |
Ivarie Robert D |
Glycosylated erythropoietin
|
EP2076530A4
(de)
*
|
2006-11-09 |
2010-04-07 |
Synageva Biopharma Corp |
Aus vögeln gewonnenes erythropoietin
|
WO2008056961A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Boryung Pharmaceutical Co., Ltd |
A novel fusion protein, cell lines expressing the same and preparation method thereof
|
KR101248252B1
(ko)
|
2006-11-28 |
2013-03-27 |
한올바이오파마주식회사 |
변형된 에리스로포이에틴 폴리펩티드와 이의 치료용 용도
|
JP5448839B2
(ja)
*
|
2006-12-22 |
2014-03-19 |
ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー |
インビボで長い半減期を有する修飾された凝固因子
|
JP2010517529A
(ja)
|
2007-02-02 |
2010-05-27 |
アムジエン・インコーポレーテツド |
ヘプシジン及びヘプシジン抗体
|
BRPI0814465B1
(pt)
|
2007-07-26 |
2021-11-23 |
Novagen Holding Corporation |
Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
|
WO2009020252A1
(en)
*
|
2007-08-08 |
2009-02-12 |
Cho-A Pharm Co., Ltd. |
Mammary gland-specific human erythropoietin expression vector, transgenic animal and method for producing human erythropoietin using same
|
CA2701032C
(en)
|
2007-09-27 |
2021-01-26 |
Amgen Inc. |
Pharmaceutical formulations
|
WO2009064838A1
(en)
|
2007-11-15 |
2009-05-22 |
Amgen, Inc. |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
NZ585555A
(en)
|
2008-01-07 |
2012-08-31 |
Synageva Biopharma Corp |
Transgenic chicken containing a transgene comprising a glycosyltransferase coding sequence
|
AU2009206306B2
(en)
|
2008-01-25 |
2013-06-06 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
WO2009139822A1
(en)
|
2008-05-01 |
2009-11-19 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
JP5507555B2
(ja)
*
|
2008-06-30 |
2014-05-28 |
チョ−エー・ファーム・カンパニー・リミテッド |
豚のαS1カゼイン遺伝子、そのプロモーター、及びその用途
|
WO2010002082A1
(en)
*
|
2008-06-30 |
2010-01-07 |
Cho-A Pharm Co., Ltd. |
A gene of porcine beta-casein, a promoter of the same and the use thereof
|
PE20110832A1
(es)
|
2008-09-26 |
2011-11-24 |
Ambrx Inc |
Polipeptidos de eritropoyetina felina modificados
|
AU2009313902B9
(en)
|
2008-11-13 |
2014-03-27 |
The General Hospital Corporation |
Methods and compositions for regulating iron homeostasis by modulation of BMP-6
|
WO2010138184A2
(en)
*
|
2009-05-27 |
2010-12-02 |
Synageva Biopharma Corp. |
Avian derived antibodies
|
US9662271B2
(en)
|
2009-10-23 |
2017-05-30 |
Amgen Inc. |
Vial adapter and system
|
JP5737597B2
(ja)
|
2009-11-19 |
2015-06-17 |
浙江大学 |
非天然コラーゲン様タンパク質及びその応用
|
EP2575935B2
(de)
|
2010-06-07 |
2023-08-23 |
Amgen Inc. |
Wirkstofffreisetzungsvorrichtung
|
WO2012015692A2
(en)
|
2010-07-28 |
2012-02-02 |
Smartcells, Inc. |
Recombinantly expressed insulin polypeptides and uses thereof
|
SG191781A1
(en)
|
2010-12-30 |
2013-08-30 |
Lab Francais Du Fractionnement |
Glycols as pathogen inactivating agents
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
CA3021845C
(en)
|
2011-04-20 |
2022-03-29 |
Amgen Inc. |
Autoinjector apparatus
|
AR087433A1
(es)
*
|
2011-08-08 |
2014-03-26 |
Merck Sharp & Dohme |
Analogos de insulina n-glicosilados
|
IL301153B2
(en)
|
2011-10-14 |
2024-05-01 |
Amgen Inc |
Syringe and assembly method
|
EP4234694A3
(de)
|
2012-11-21 |
2023-09-06 |
Amgen Inc. |
Arzneimittelabgabevorrichtung
|
CN105263319A
(zh)
|
2013-02-13 |
2016-01-20 |
法国化学与生物科技实验室 |
具有经修饰的糖基化的蛋白及其生产方法
|
CA2900909A1
(en)
|
2013-02-13 |
2014-08-21 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Highly galactosylated anti-tnf-.alpha. antibodies and uses thereof
|
EP3693381A1
(de)
|
2013-02-18 |
2020-08-12 |
Vegenics Pty Limited |
Ligandbindende moleküle und verwendungen davon
|
TWI580452B
(zh)
|
2013-03-15 |
2017-05-01 |
安美基公司 |
用於注射器之匣盒、注射器及使用包括自動注射器及匣盒之設備之方法
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
DK2968503T3
(en)
|
2013-03-15 |
2018-12-03 |
Intrinsic Lifesciences Llc |
ANTI-HEPCIDIN ANTIBODIES AND APPLICATIONS THEREOF
|
CN105377327B
(zh)
|
2013-03-22 |
2021-06-22 |
安姆根有限公司 |
注射器及装配方法
|
PL3016729T3
(pl)
|
2013-07-05 |
2020-09-07 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies Société Anonyme |
Matryca do chromatografii powinowactwa
|
EP3060281B1
(de)
|
2013-10-24 |
2019-01-30 |
Amgen Inc. |
Arzneimittelabgabesystem mit temperaturempfindlicher steuerung
|
SG11201602876WA
(en)
|
2013-10-24 |
2016-05-30 |
Amgen Inc |
Injector and method of assembly
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
US10722655B2
(en)
|
2014-05-07 |
2020-07-28 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
CN106470716B
(zh)
|
2014-06-03 |
2020-07-17 |
安姆根有限公司 |
可控制药物递送系统和使用方法
|
US10323088B2
(en)
|
2014-09-22 |
2019-06-18 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
CA2957960C
(en)
|
2014-10-14 |
2023-08-22 |
Amgen, Inc. |
Drug injection device with visual and audible indicators
|
EP3233159B1
(de)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Medikamentenabgabevorrichtung mit beweglicher taste oder bedienfeld
|
ES2898469T3
(es)
|
2014-12-19 |
2022-03-07 |
Amgen Inc |
Dispositivo de administración de medicamentos con sensor de proximidad
|
JP6484345B2
(ja)
|
2015-02-17 |
2019-03-20 |
アムジエン・インコーポレーテツド |
固定及び/または戻りが真空によって支援された薬物送達装置
|
US11806509B2
(en)
|
2015-02-27 |
2023-11-07 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a turnable threshold of resistance to needle guard movement
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
WO2017068185A1
(en)
|
2015-10-23 |
2017-04-27 |
Apogenix Ag |
Single-chain gitr-receptor agonist proteins
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
EP4035711A1
(de)
|
2016-03-15 |
2022-08-03 |
Amgen Inc. |
Verringerung der wahrscheinlichkeit auf glasbruch in arzneimittelabgabevorrichtungen
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
US10988284B2
(en)
|
2016-05-13 |
2021-04-27 |
Amgen Inc. |
Vial sleeve assembly
|
EP3458988B1
(de)
|
2016-05-16 |
2023-10-18 |
Amgen Inc. |
Datenverschlüsselung in medizinischen vorrichtungen mit eingeschränkter rechenfähigkeit
|
EP3465124A1
(de)
|
2016-06-03 |
2019-04-10 |
Amgen Inc. |
Wirkungstestvorrichtungen und verfahren für wirkstofffreisetzungsvorrichtungen
|
EP3478342A1
(de)
|
2016-07-01 |
2019-05-08 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit minimiertem teilebruchrisiko nach aufprallereignissen
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
MX2019009625A
(es)
|
2017-02-17 |
2019-10-09 |
Amgen Inc |
Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje.
|
US11369736B2
(en)
|
2017-02-17 |
2022-06-28 |
Amgen Inc. |
Cannula insertion and retraction mechanisms
|
WO2018165143A1
(en)
|
2017-03-06 |
2018-09-13 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
EP3592402A1
(de)
|
2017-03-07 |
2020-01-15 |
Amgen Inc. |
Nadeleinführung durch überdruck
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
CN110446499A
(zh)
|
2017-03-20 |
2019-11-12 |
豪夫迈·罗氏有限公司 |
一种体外糖基工程化红细胞生成刺激蛋白的方法
|
BR112019020053B1
(pt)
|
2017-03-28 |
2023-10-10 |
Amgen Inc |
Máquina para acoplar uma haste de êmbolo a um conjunto de seringa e método de utilização da referida máquina
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
US11904143B2
(en)
|
2017-06-08 |
2024-02-20 |
Amgen Inc. |
Torque driven drug delivery device
|
CA3063920A1
(en)
|
2017-06-22 |
2018-12-27 |
Amgen Inc. |
Device activation impact/shock reduction
|
US11395880B2
(en)
|
2017-06-23 |
2022-07-26 |
Amgen Inc. |
Electronic drug delivery device
|
MA49562A
(fr)
|
2017-07-14 |
2020-05-20 |
Amgen Inc |
Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion
|
EP3655063A1
(de)
|
2017-07-21 |
2020-05-27 |
Amgen Inc. |
Gasdurchlässiges dichtelement für arzneimittelbehälter und verfahren zur montage
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
EP4085942A1
(de)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit getriebemodul und verwandtes verfahren zur montage
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
EP3668567A1
(de)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Am körper tragbarer injektor mit sterilem klebepflaster
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
MA50611A
(fr)
|
2017-10-04 |
2020-08-12 |
Amgen Inc |
Adaptateur d'écoulement destiné à un dispositif d'administration de médicament
|
WO2019070552A1
(en)
|
2017-10-06 |
2019-04-11 |
Amgen Inc. |
DRUG DELIVERY DEVICE COMPRISING A LOCKOUT ASSEMBLY AND ASSOCIATED ASSEMBLY METHOD
|
US11464903B2
(en)
|
2017-10-09 |
2022-10-11 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
EP3703778A1
(de)
|
2017-11-03 |
2020-09-09 |
Amgen Inc. |
System und ansätze zum sterilisieren einer arzneimittelabgabevorrichtung
|
US20200338271A1
(en)
|
2017-11-06 |
2020-10-29 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
CA3079197A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
CN116832271A
(zh)
|
2017-11-10 |
2023-10-03 |
安进公司 |
用于药物递送装置的柱塞
|
MX2020004996A
(es)
|
2017-11-16 |
2020-08-27 |
Amgen Inc |
Un mecanismo de pestillo de puerta para un dispositivo de administracion de farmacos.
|
CN111263651B
(zh)
|
2017-11-16 |
2022-06-17 |
安进公司 |
具有停顿和终点检测的自动注射器
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
US20210260279A1
(en)
|
2018-07-24 |
2021-08-26 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
WO2020023451A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
MA53379A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
US20210228797A1
(en)
|
2018-07-31 |
2021-07-29 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
AU2019347710A1
(en)
|
2018-09-24 |
2021-02-04 |
Amgen Inc. |
Interventional dosing systems and methods
|
CA3110371A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
MA53815A
(fr)
|
2018-10-02 |
2022-01-05 |
Amgen Inc |
Systèmes d'injection pour administration de médicament avec transmission de force interne
|
US20210338936A1
(en)
|
2018-10-05 |
2021-11-04 |
Amgen Inc. |
Drug delivery device having dose indicator
|
TW202031306A
(zh)
|
2018-10-15 |
2020-09-01 |
美商安進公司 |
用於藥物遞送裝置之平台組裝方法
|
US20200114082A1
(en)
|
2018-10-15 |
2020-04-16 |
Amgen Inc. |
Drug delivery device having damping mechanism
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
WO2020091981A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
AU2020263289A1
(en)
|
2019-04-24 |
2021-09-16 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
US20220273887A1
(en)
|
2019-08-23 |
2022-09-01 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
CA3191387A1
(en)
|
2020-09-30 |
2022-04-07 |
Nobell Foods, Inc. |
Recombinant milk proteins and food compositions comprising the same
|
US10894812B1
(en)
|
2020-09-30 |
2021-01-19 |
Alpine Roads, Inc. |
Recombinant milk proteins
|
US10947552B1
(en)
|
2020-09-30 |
2021-03-16 |
Alpine Roads, Inc. |
Recombinant fusion proteins for producing milk proteins in plants
|
EP4341161A1
(de)
|
2021-05-21 |
2024-03-27 |
Amgen Inc. |
Verfahren zur optimierung eines füllrezepts für einen arzneimittelbehälter
|
WO2024094457A1
(en)
|
2022-11-02 |
2024-05-10 |
F. Hoffmann-La Roche Ag |
Method for producing glycoprotein compositions
|